The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
430 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $560,509,761 in first-year total cost, median $806,958.
Most frequent study sections
- Special Emphasis Panel[ZRG1 BDCN-A (55)]39
- Special Emphasis Panel[ZRG1 MDCN-P (56)]23
- Clinical Neuroscience and Neurodegeneration Study Section[CNN]22
- Special Emphasis Panel[ZRG1 PSE-C (55)]22
- Neurological, Aging and Musculoskeletal Epidemiology Study Section[NAME]17
Most frequent institutions
- COLUMBIA UNIVERSITY HEALTH SCIENCES20
- EMORY UNIVERSITY16
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO15
- UNIVERSITY OF CALIFORNIA, SAN DIEGO14
- MASSACHUSETTS GENERAL HOSPITAL13
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2023 | Leveraging Electronic Health Records for Reducing Dementia Screening Disparities in Diverse Communities1R01AG079175-01 | BRODY, ABRAHAM AIZERDODSON, JOHN ARAZAVIAN, NARGES | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $843,010 | CIDH |
| 2023 | Vulnerability Profiles of Comorbid Alzheimer and TDP-43 Proteinopathies in Amnestic Dementia1R56AG075600-01A1 | GEFEN, TAMAR D | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $603,031 | CNN |
| 2022 | Plasma Proteomic Signatures for Alzheimer's Disease and Related Dementias1RF1AG079149-01 | MCEVOY, LINDA KATHLEENSHADYAB, ALADDIN | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $7,523,227 | ZRG1 |
| 2022 | Study of Latinos-Investigation of Neurocognitive Aging-Alzheimer's disease1R01AG075758-01 | DECARLI, CHARLESGONZALEZ, HECTOR M | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $6,679,538 | APDA |
| 2022 | Alzheimer's Disease and Related Dementias (ADRD) prevalence in American Samoa1RF1AG075904-01A1 | GALVIN, JAMES ETOFAEONO, VAATAUSILI T | AMERICAN SAMOA COMMUNITY CANCER COALITIO, AS | $6,186,533 | ZRG1 |
| 2022 | Biomarker Evaluation in Young Onset Dementia from Diverse Populations (BEYONDD)1R56AG075744-01A1 | BOXER, ADAM L.BYRD, DESIREE ARABINOVICI, GIL DANRIVERA-MINDT, MONICA G. | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $6,065,228 | ZRG1 |
| 2022 | The role of 24-hour activity cycles in preserving cognitive function and preventing Alzheimer's disease and related dementias1RF1AG077707-01 | DIAZ, KEITH MGABRIEL, KELLEY PETTEEPALTA, PRIYA | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $5,450,271 | BMHO |
| 2022 | The Origins of Alzheimer Disease in African Americans1R01AG072547-01A1 | AKINYEMI, RUFUS OLUSOLABEECHAM, GARY WAYNEBYRD, GOLDIE S.CABAN-HOLT, ALLISON MERCEDESHAINES, JONATHAN LPERICAK-VANCE, MARGARET A.REITZ, CHRISTIANEWILLIAMS, SCOTT MATTHEW | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $5,298,109 | ZRG1 |
| 2022 | Sex-specific risk factors and trajectories of blood biomarkers for Alzheimer's disease and related dementias1RF1AG079397-01 | MIELKE, MICHELLE MMURRAY, ANNE MRYAN, JOANNE | HENNEPIN HEALTHCARE RESEARCH INSTITUTE, MN | $4,159,504 | ZRG1 |
| 2022 | Full human gene replacement mouse models of Alzheimer's Disease1RF1AG079125-01 | KOOB, MICHAEL DLAMB, BRUCE T | UNIVERSITY OF MINNESOTA, MN | $4,147,326 | MNG |
| 2022 | Cognitive Aging, Brain Morphology, and Arrhythmias in Hispanics/Latinos: Implications for Prevention and Management of Alzheimer's Disease-Related Dementias1RF1NS127266-01 | CHEN, LIN YEEGONZALEZ, HECTOR MMATSUSHITA, KUNIHIRO | UNIVERSITY OF MINNESOTA, MN | $4,131,388 | ZRG1 |
| 2022 | Integrating Information about Aging Surveys: Novel Integration of Contextual Data to Study Late-Life Cognition and Alzheimer’s Disease and Related Dementia and Dementia Care2R01AG030153-17 | ADAR, SARAGROSS, ALDEN L.LEE, JINKOOK | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $4,006,084 | SSPA |
| 2022 | The effects of Alzheimer's disease risk genes on metabolism and signaling across cell types1RF1AG075901-01A1 | FRAENKEL, ERNESTTSAI, LI-HUEI | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $3,944,334 | NOMD |
| 2022 | Myosteatosis, Cognition and Blood Biomarkers of Alzheimer's Disease in Persons of African Ancestry1RF1AG077474-01 | MILJKOVIC, IVAROSANO, CATERINA | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $3,212,010 | ZRG1 |
| 2022 | Testing Hypothesized Pathways Linking Infection, Physical Activity, Apoe Genotype, And Biological Sex To Low Dementia Prevalence And Reduced Brain Atrophy In Two Native American Populations2R01AG054442-03 | FINCH, CALEB EGATZ, MARGARETGURVEN, MICHAEL DOUGLASKAPLAN, HILLARD SSTIEGLITZ, JONATHAN PTHOMAS, GREGORY SCOTTTHOMPSON, RANDALLTRUMBLE, BENJAMIN CHAPIN | CHAPMAN UNIVERSITY, CA | $3,199,665 | NAME |
| 2022 | Deep Phenotypic Characterization of Prodromal Dementia with Lewy Bodies1R56AG074889-01A1 | GALVIN, JAMES E | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $3,171,435 | CNN |
| 2022 | Investigating regional and cellular vulnerabilities to tau pathology in young-onset Alzheimer's disease1R01AG075802-01 | GHETTI, BERNARDINO FRANCESCOGRINBERG, LEA TENENHOLZMURRAY, MELISSA ERIN | MAYO CLINIC JACKSONVILLE, FL | $3,067,743 | ZRG1 |
| 2022 | Single-cell multi-region transcriptional and epigenomic dissection of VCID.1RF1NS129032-01 | HEIMAN, MYRIAMKELLIS, MANOLIS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $3,058,535 | ZRG1 |
| 2022 | I3C DECADE: Disparities and Equity in Childhood Cardiovascular Exposures and Alzheimer's Dementia1R01AG077497-01 | BAZZANO, LYDIACARMICHAEL, OWEN T.URBINA, ELAINE MOTT | TULANE UNIVERSITY OF LOUISIANA, LA | $2,891,965 | ZRG1 |
| 2022 | Elucidating a microgliaassociated role for SORLA in modulating AD pathogenesis1RF1AG070391-01A1 | HUANG, TIMOTHY YIKAI | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $2,818,493 | CMBG |
| 2022 | Stress, Weathering, and Blood-Based Biomarkers of Alzheimer’s Disease: A Longitudinal Study of Low Income, Aging African Americans1RF1AG077386-01 | MIELKE, MICHELLE MSIMONS, RONALD L | UNIVERSITY OF GEORGIA, GA | $2,788,814 | ZRG1 |
| 2022 | The Longitudinal Course of Imaging Biomarkers in People At Risk for Alzheimer’s Disease2R01AG021155-16 | JOHNSON, STERLING C | UNIVERSITY OF WISCONSIN-MADISON, WI | $2,631,491 | CNN |
| 2022 | Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease1R01AG079241-01 | ALBER, JESSICA | UNIVERSITY OF RHODE ISLAND, RI | $2,566,363 | ZRG1 |
| 2022 | Functional analysis of glia in tauopathy1RF1AG076214-01A1 | FEANY, MEL BFRAENKEL, ERNEST | BRIGHAM AND WOMEN'S HOSPITAL, MA | $2,531,613 | ZRG1 |
| 2022 | Predictors of Altered CNS Structure, Function, and Connectomics in the Elderly using a Health Disparities Framework1R01AG072641-01A1 | COHEN, ANN D. | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $2,416,844 | ZRG1 |
| 2022 | Lifecourse food insecurity and dementia risk1RF1AG079202-01 | MARTINEZ, SUZANNA MVABLE, ANUSHA MURTHY | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $2,410,106 | ZRG1 |
| 2022 | The confluence of extreme heat cold on the health and longevity of an Aging Population with Alzheimers and related Dementia1RF1AG074372-01A1 | DOMINICI, FRANCESCAESTIRI, HOSSEINPATEL, CHIRAG J. | HARVARD MEDICAL SCHOOL, MA | $2,385,541 | ZRG1 |
| 2022 | Validating remote digital assessments for familial frontotemporal dementia1RF1AG077557-01 | STAFFARONI, ADAM MARK | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $2,371,437 | APDA |
| 2022 | Assessing the Long-term Impact of COVID-induced Telemedicine Expansion on Dementia Care1RF1AG077623-01 | ADLER-MILSTEIN, JULIA ROSE | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $2,340,878 | ZRG1 |
| 2022 | Untangling the diversity in the genetic architecture of late-onset Alzheimer's disease using single cell multi-omics1RF1AG077695-01 | CHIBA-FALEK, ORNIT | DUKE UNIVERSITY, NC | $2,333,875 | MNG |
| 2022 | Understanding the functional impacts of Aβ variants in Alzheimer's disease with human brain organoids1RF1AG079256-01 | BOMMARIUS, ANDREAS SLIANG, BOLYNN, DAVID GILBERTWEN, ZHEXING | EMORY UNIVERSITY, GA | $2,333,853 | CMND |
| 2022 | Quantitative UTE MR Imaging of Myelin: Novel Biomarkers for Alzheimer's Disease1RF1AG075717-01A1 | DU, JIANG | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $2,319,212 | EITN |
| 2022 | Digital Biomarkers for Vascular Cognitive Decline in Patients with Minor Stroke1RF1AG079324-01 | MARSH, ELISABETH BREESEMOSHER, JOHN COMPTON | JOHNS HOPKINS UNIVERSITY, MD | $2,310,293 | ANIE |
| 2022 | ncRNAs in plasma EVs of AD patients and their discriminatory power as biomarkers1RF1AG075992-01A1 | KOLDAMOVA, RADOSVETALEFTEROV, ILIYA | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $2,297,526 | ZRG1 |
| 2022 | Genomic and Metabolomic Data Integration in a Longitudinal Cohort at Risk for Alzheimer's Disease2RF1AG054047-06A1 | ENGELMAN, CORINNE D. | UNIVERSITY OF WISCONSIN-MADISON, WI | $2,285,690 | ZRG1 |
| 2022 | Modeling the Genetic Interaction Between Klotho and APOE Alleles in Alzheimer's Disease1RF1AG075701-01A1 | CARTER, GREGORY WSASNER, MICHAEL | JACKSON LABORATORY, ME | $2,281,779 | ZRG1 |
| 2022 | Entorhinal-hippocampal interactions during progressive memory impairments in mouse models of Alzheimer's disease pathology1RF1AG072497-01A1 | SHUMAN, TRISTAN | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $2,271,330 | LMDN |
| 2022 | Longitudinal Examination of Neighborhood Disadvantage, Cognitive Aging, and Alzheimer's Disease Risk in Disinvested, African American Neighborhoods1R01AG072652-01A1 | DUBOWITZ, TAMARAROSSO, ANDREA LTROXEL, WENDY M | RAND CORPORATION, CA | $2,267,650 | NAME |
| 2022 | Automated cell-type-specific electrophysiology for understanding circuit dysregulation in Alzheimer's Disease1RF1AG079269-01 | FOREST, CRAIGROWAN, MATTHEW J.M. | EMORY UNIVERSITY, GA | $2,263,275 | BNVT |
| 2022 | Temporal, Spatial and Cellular Dynamics of Amyloid Plaque Deposition1RF1AG079185-01 | GLABE, CHARLES G. | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $2,261,484 | ZRG1 |
| 2022 | Microglial function of GWAS risk factor BIN1 in Alzheimer's disease pathogenesis and inflammatory signaling1RF1AG079141-01 | RANGARAJU, SRIKANTTHINAKARAN, GOPAL | UNIVERSITY OF SOUTH FLORIDA, FL | $2,250,452 | ZRG1 |
| 2022 | Immunovascular interactions in postoperative delirium superimposed on dementia (DSD).1RF1AG079138-01 | GELBARD, HARRIS ATERRANDO, NICCOLO | DUKE UNIVERSITY, NC | $2,244,681 | CDIN |
| 2022 | In vivo Identification of Pre-Atrophic Brain Neurodegeneration in Prodromal Alzheimer Disease with Quantitative Gradient Recalled Echo MRI1RF1AG077658-01 | YABLONSKIY, DMITRIY A | WASHINGTON UNIVERSITY, MO | $2,231,917 | EITN |
| 2022 | Intranasal Treatment of Stem Cell-derived Extracellular Vesicles for Alzheimer's Disease1RF1AG074256-01A1 | SHETTY, ASHOK K | TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR, TX | $2,212,694 | ZRG1 |
| 2022 | Digital detection of social isolation and loneliness markers of risk for Alzheimer's disease1RF1AG075889-01A1 | DEPP, COLIN A.GRANHOLM, ERIC L | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $2,192,996 | APDA |
| 2022 | Capturing the molecular complexity of tau pathology-associated proteomes involved in the etiology of Alzheimer's disease and related dementias1RF1AG076122-01A1 | ROSSOLL, WILFRIED | MAYO CLINIC JACKSONVILLE, FL | $2,183,377 | ZRG1 |
| 2022 | The role of Alzheimer's disease GWAS risk factor BIN1 in tau neuropathology and propagation in vivo1RF1AG077610-01 | THINAKARAN, GOPAL | UNIVERSITY OF SOUTH FLORIDA, FL | $2,174,618 | CMND |
| 2022 | α-Synuclein strain properties are associated with diagnosis of and progression to Parkinson's disease with dementia1RF1NS125592-01 | MAO, XIAOBOROSENTHAL, LIANA ISA SHAPIRO | JOHNS HOPKINS UNIVERSITY, MD | $2,133,267 | CMND |
| 2022 | Mechanisms by which ABCA7 activity influences Alzheimer's Disease1RF1AG079331-01 | RADER, DANIEL JAMES | UNIVERSITY OF PENNSYLVANIA, PA | $2,121,130 | CMND |
| 2022 | Resolving the function of progranulin in lysosomal lipid metabolism and the etiology of Alzheimer's disease and frontotemporal dementia1RF1AG079318-01 | KUKAR, THOMAS L | EMORY UNIVERSITY, GA | $2,098,104 | ZRG1 |
| 2022 | Immunotherapy Targeting Tau Aggregate Polymorphs1RF1AG077484-01 | KAYED, RAKEZ | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $2,009,600 | DDNS |
| 2022 | Nerve growth factor (NGF) metabolic dysfunction as a marker of cognitive decline in autosomal dominant Alzheimer's disease1RF1AG077627-01 | AGUILLON, DAVID FERNANDOCUELLO, A CLAUDIOQUIROZ, YAKEEL T. | MASSACHUSETTS GENERAL HOSPITAL, MA | $1,969,396 | ZRG1 |
| 2022 | Sleep, Pericytes, and Alzheimer's Disease1RF1AG077570-01 | LIU, MENG | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $1,955,041 | ZRG1 |
| 2022 | Reduced BBB Water Exchange as a Preclinical Biomarker of Small Vessel Disease1RF1NS122028-01A1 | GOLD, BRIAN TIMOTHYWANG, DANNY JJ | UNIVERSITY OF KENTUCKY, KY | $1,952,654 | ZRG1 |
| 2022 | Define the effect of CLU SNP on the risk to Alzheimer's disease1RF1AG079307-01 | SHI, YANHONG | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $1,942,962 | ZRG1 |
| 2022 | Neuroinflammatory mechanisms underlying sepsis-induced cognitive dysfunction1RF1AG075341-01A1 | BASTARACHE, JULIE ANNEHARRISON, FIONA EDITH | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $1,940,638 | CDIN |
| 2022 | MicroRNA Mouse Models and Alzheimer’s Disease1RF1AG079264-01 | REDDY, P. HEMACHANDRA | TEXAS TECH UNIVERSITY HEALTH SCIS CENTER, TX | $1,862,337 | ZRG1 |
| 2022 | Structure and Genesis of tau Aggregates2RF1AG054018-02 | KURET, JEFF | OHIO STATE UNIVERSITY, OH | $1,821,723 | MSFB |
| 2022 | Addressing Alzheimer's Disease and Related Dementias Disparities: The American Indigenous Cognitive Assessment (AMICA) Project1R01AG074231-01A1 | GLEASON, CAREY EJACKLIN, KRISTENPARKER, TASSY | UNIVERSITY OF MINNESOTA, MN | $1,800,689 | ZRG1 |
| 2022 | The role of peripheral versus brain myeloid immunity in the cognitive decline of aging and Alzheimer's disease1RF1AG079131-01 | ANDREASSON, KATRIN I. | STANFORD UNIVERSITY, CA | $1,749,426 | ZRG1 |
| 2022 | Sex Differences in Epigenetic Parent-of-X Origin and Alzheimer's Disease1RF1AG079176-01 | DUBAL, DENA BOU | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $1,743,758 | MNG |
| 2022 | Vascular mechanisms of inhibition of sEH as a novel therapy for AD/ADRD1RF1AG079336-01 | FAN, FANROMAN, RICHARD J. | UNIVERSITY OF MISSISSIPPI MED CTR, MS | $1,720,413 | ZRG1 |
| 2022 | Priming the proteasome to protect against aging and Alzheimer's disease1RF1AG072510-01A1 | WANG, HONGMINWANG, XUEJUN | UNIVERSITY OF SOUTH DAKOTA, SD | $1,625,919 | NOMD |
| 2022 | Characterizing Alzheimer's Amyloid-beta Oligomer Structures by Solid-State NMR and Cryo-Electron Microscopy1RF1AG073434-01A1 | PARAVASTU, ANANT KRISHNAROSENBERRY, TERRONE LSTAGG, SCOTT MZHOU, HUAN-XIANG | GEORGIA INSTITUTE OF TECHNOLOGY, GA | $1,623,119 | MSFB |
| 2022 | Protective Genetic Variants for Alzheimer Disease in the Amish - RENEWAL2R01AG058066-02 | HAINES, JONATHAN LPERICAK-VANCE, MARGARET A.SCOTT, WILLIAM K | CASE WESTERN RESERVE UNIVERSITY, OH | $1,604,416 | ZRG1 |
| 2022 | Contribution of neuromelanin to selective vulnerability of locus coeruleus neurons in Alzheimer's disease1RF1AG079199-01 | WEINSHENKER, DAVID | EMORY UNIVERSITY, GA | $1,531,573 | ZRG1 |
| 2022 | Validation of Video Administration of a Modified UDSv3 Cognitive Battery1R01AG075959-01 | RAPP, STEPHEN RSACHS, BONNIE | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $1,467,486 | APDA |
| 2022 | Influence of thalamic IL-33 signaling in aging-associated exacerbation of cognitive impairment after brain injury via microglial dysfunction and tau pathology1RF1AG079129-01 | KANO, SHINICHI | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $1,452,959 | CMBG |
| 2022 | Early and life course socioeconomic adversity and dementia risk in Hispanics/Latinos1RF1AG077639-01 | DECARLI, CHARLESGONZALEZ, HECTOR MISASI, CARMEN R. | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | $1,441,831 | ZRG1 |
| 2022 | Upregulated Norepinephrine Synthesis Capacity in Aging1R01AG074330-01A1 | BERRY, ANNE SHIVELY | BRANDEIS UNIVERSITY, MA | $1,386,326 | CNN |
| 2022 | Identifying resilience proteins in key motor tissues that drive motor and cognitive decline and offset the negative effects of ADRD pathologies within and outside the brain1R01AG075728-01 | BUCHMAN, ARON S | RUSH UNIVERSITY MEDICAL CENTER, IL | $1,354,497 | NAME |
| 2022 | Study of Selective Cell and System Vulnerability in Alzheimer's Disease1R56AG079291-01 | GAN, LILI, YUNSHEN, YIN | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $1,344,626 | GCAT |
| 2022 | Hyperphosphorylated tau and the molecular mechanisms of tauopathy1RF1AG077475-01 | KUO, MIN-HAO | MICHIGAN STATE UNIVERSITY, MI | $1,337,894 | NOMD |
| 2022 | Role of PLD3 in nucleic acid recognition and brain function1RF1AG070775-01A1 | NEMAZEE, DAVID | SCRIPPS RESEARCH INSTITUTE, THE, CA | $1,331,250 | CMBG |
| 2022 | Neuroprotective signaling and transcriptional pathways in microglia associated with Alzheimer's disease1R01AG072489-01A1 | GOATE, ALISON MSCHAEFER, ANNETARAKHOVSKY, ALEXANDER | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $1,224,125 | CMBG |
| 2022 | The Black American United Memory & Aging Project (BA-UMAP): An examination of cognitive decline in midlife and older Black adults using remote cognitive assessments, risk factors & biomarkers1R01AG079388-01 | BROWN-HUGHES, TRAVONIA SGRAHAM, STEWART FTHORPE, ROLAND J. | HAMPTON UNIVERSITY, VA | $1,129,418 | ZRG1 |
| 2022 | Towards Treatment of Alzheimer’s Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures1R01AG070895-01A1 | EISENBERG, DAVID | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $1,068,405 | BPNS |
| 2022 | Project HoPe: Achieving Home Discharge for institutionally-bound Patients with PROMs, AI, and the EHR1R01AG077706-01 | CHEVILLE, ANDREA LYNNE | MAYO CLINIC ROCHESTER, MN | $1,047,570 | ZRG1 |
| 2022 | Preeclampsia and the Brain: Small vessel disease and cognitive function in early midlife1R01AG072646-01A1 | CATOV, JANET MROSANO, CATERINA | MAGEE-WOMEN'S RES INST AND FOUNDATION, PA | $953,540 | ZRG1 |
| 2022 | Characterizing the Behavior Profile of Healthy Cognitive Aging2R01AG034374-11 | BOYLE, PATRICIA A | RUSH UNIVERSITY MEDICAL CENTER, IL | $940,498 | ZRG1 |
| 2022 | Towards Precision Nutrition for Alzheimer's Dementia Prevention: A Prospective Study of Dietary Patterns, the Gut Microbiome and Cognitive Function1R01AG077489-01 | WANG, DONG | BRIGHAM AND WOMEN'S HOSPITAL, MA | $917,501 | KNOD |
| 2022 | Tracking autobiographical thoughts: a smartphone-based approach to identifying cognitive correlates of Alzheimer's disease biomarkers and risk factors in clinically normal older adults1R01AG068098-01A1 | ANDREWS-HANNA, JESSICA RENEEGRILLI, MATTHEW D | UNIVERSITY OF ARIZONA, AZ | $894,758 | ZRG1 |
| 2022 | Effects of vascular risk factors on risk for dementia and stroke after late-onset epilepsy (EpilepsyCOG)1R01AG074355-01A1 | CHOI, HYUNMIGUTIERREZ, JOSETHACKER, EVAN LLOYD | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $893,219 | ZRG1 |
| 2022 | Prospective Change in Preclinical MRI Markers of ADRD Risk and Brain Aging by Race, Socioeconomic Status, and Sex1R56AG064088-01A1 | WALDSTEIN, SHARI | UNIVERSITY OF MARYLAND BALTIMORE COUNTY, MD | $862,577 | ZRG1 |
| 2022 | Cerebral hemodynamic impairment in symptomatic and asymptomatic Alzheimer's Disease1R01AG072603-01A1 | QIU, DEQIANG | EMORY UNIVERSITY, GA | $857,527 | CNN |
| 2022 | Age-related Hypertension and Vascular Cognitive Impairment1R01AG075963-01 | FARB, DAVID HWAINFORD, RICHARD DAVID | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $835,492 | ZRG1 |
| 2022 | Visual-somatosensory integration as a novel marker of Alzheimer's disease1R01AG075679-01 | MAHONEY, JEANNETTE R. | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | $834,557 | ASG |
| 2022 | Perceived racism, cardiovascular disease risk, and neurocognitive aging1R01AG074213-01A1 | SCHON, KARIN | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $831,723 | MESH |
| 2022 | Palliative Care at Home for Patients with Dementia1R01AG067045-01A1 | GOLDSTEIN, NATHAN E | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $831,304 | CMGC |
| 2022 | Novel application of Digital signals of movement, sleep and heart rhythms for detection of Alzheimer's Disease and Related Dementias1R01AG075883-01A1 | CHEN, LIN YEECRAINICEANU, CIPRIAN MSCHRACK, JENNIFER ANNSPIRA, ADAM PETER | JOHNS HOPKINS UNIVERSITY, MD | $826,153 | ZRG1 |
| 2022 | Cerebrovascular Remodeling and Neurodegenerative Changes in Alzheimer's Disease1R01AG075876-01 | STEIN, THORZAIA, JOSEPHZHANG, YANHANG KATHERINE | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA | $824,997 | ZRG1 |
| 2022 | Salivary Extracellular Vesicles as Biomarkers for Alzheimer's Disease and Related Disorders1R01AG074284-01A1 | KREILING, JILLQUESENBERRY, PETER J. | BROWN UNIVERSITY, RI | $822,130 | ZRG1 |
| 2022 | Formation and Propagation of Tau Oligomeric Strains in Alzheimer's Disease2R01AG054025-06A1 | KAYED, RAKEZ | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $805,576 | CMND |
| 2022 | Immune Cells in Alzheimer’s Disease and Related Dementias in the Jackson Heart Study1R01AG075884-01 | RAFFIELD, LAURA M | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $804,770 | ZRG1 |
| 2022 | Quantifying Individual Differences in Midlife Structural Brain Integrity Associated with Later AD/ADRD Risk2R01AG049789-06 | HARIRI, AHMAD R.MOFFITT, TERRIE E | DUKE UNIVERSITY, NC | $800,463 | APDA |
| 2022 | Learning Skills Together: A Randomized Controlled Trial of a Complex Care Skills Intervention to Improve AD/ADRD Caregiver Self-Efficacy1R01AG077554-01 | MEYER, KYLIE NICOLE | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | $794,835 | SPIP |
| 2022 | Using Informatics to Evaluate and Predict Cataract Surgery Impact on Alzheimer's Disease and Related Dementias and Mild Cognitive Impairment Outcomes1R01AG072582-01A1 | PERSHING, SUZANN | STANFORD UNIVERSITY, CA | $793,778 | ZRG1 |
| 2022 | Statistical Methods for Kidney Markers as Shared Determinants of Dementia and Physical Disability in Older Adults2R01AG048069-05A1 | SHARDELL, MICHELLE DENISE | UNIVERSITY OF MARYLAND BALTIMORE, MD | $793,481 | ZRG1 |
| 2022 | Personalized OSA treatment and effects on AD biomarkers and cognition among blacks1R01AG075007-01A1 | JEAN-LOUIS, GIRARDINSEIXAS, AZIZI | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $786,803 | ZRG1 |
| 2022 | Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids1R01AG079223-01 | WANG, YANLING | RUSH UNIVERSITY MEDICAL CENTER, IL | $785,933 | ZRG1 |
| 2022 | Exploring irisin as a novel target for Alzheimers Disease1R56AG072054-01A1 | CHOI, SE HOONWRANN, CHRISTIANE D. | MASSACHUSETTS GENERAL HOSPITAL, MA | $785,194 | NOMD |
| 2022 | Evaluating a National Person-Centered Training Program to Strengthen the Dementia Care Workforce1R01AG079124-01 | ZIMMERMAN, SHERYL | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $784,653 | ZRG1 |
| 2022 | The risks and consequences of a motor vehicle crash in older adults with Alzheimer's Disease and Related Dementias1R01AG079295-01 | JOYCE, NINA | BROWN UNIVERSITY, RI | $784,027 | ZRG1 |
| 2022 | Characterizing Older Mexican (American) Participation in Activity Digitally, Reliably, and Ecologically with the CART Platform (COMPADRE CART): Implications for Cognition and ADRD1R01AG077472-01 | BEATTIE, ZACHARYGONZALES, MITZI MICHELLE | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | $783,114 | ZRG1 |
| 2022 | Impaired Vasoreactivity, Sleep Degradation, and Impaired Clearance in the APOE4 Brain1R01AG072513-01A1 | DREW, PATRICK JAMESGLUCKMAN, BRUCE JPROCTOR, ELIZABETH A | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $776,419 | CDIN |
| 2022 | The Beaver Dam Offspring Study Neurocognitive Aging Study (BOSS-NCAS)-A Study on the Role of Accelerated Aging and Midlife Sensory Decline for Early Alzheimer’s Disease and Dementia in Later Life1R01AG079289-01 | MERTEN, NATASCHA | UNIVERSITY OF WISCONSIN-MADISON, WI | $775,611 | ZRG1 |
| 2022 | Olfactory Phenotypes as Non-Invasive Biomarkers for Alzheimer's Disease: A Machine Learning Approach1R01AG072624-01A1 | VILLWOCK, JENNIFER | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $774,582 | ZRG1 |
| 2022 | Extreme weather-related events and environmental exposures in the risk for Alzheimer's disease and related dementias1R01AG074347-01A1 | CONLON, KATHRYN C | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $768,051 | ZRG1 |
| 2022 | Using a novel mTBI model to investigate phosphorylation dependent common mechanisms in tauopathies1R01AG075809-01 | EBNER, TIMOTHY JKOOB, MICHAEL DLIAO, DEZHI | UNIVERSITY OF MINNESOTA, MN | $767,250 | CMND |
| 2022 | Uncovering cell-type-specific driver genes of Alzheimer's Disease by pathology-indexing scRNA-seq, spatial transcriptomics, and CRISPR screens1R01AG074082-01A1 | WANG, YANLING | RUSH UNIVERSITY MEDICAL CENTER, IL | $766,665 | ZRG1 |
| 2022 | Neural Circuit Disruption in Freely-Behaving models of Alzheimer's Disease.1R01AG077611-01 | GOMPERTS, STEPHEN N. | MASSACHUSETTS GENERAL HOSPITAL, MA | $765,473 | CMND |
| 2022 | Investigating the role of Alzheimer's disease familial mutations in neuromuscular physiology1R01AG077651-01 | HICKMAN, JAMES JMORGAN, DAVID | UNIVERSITY OF CENTRAL FLORIDA, FL | $764,558 | BNVT |
| 2022 | Air pollution and early signs of dementia1R01AG079170-01 | HUELS, ANKEWINGO, THOMAS SPURGEON | EMORY UNIVERSITY, GA | $763,967 | ZRG1 |
| 2022 | Integrative genomic, transcriptomic, and proteomic analyses to investigate sex-specific differences in Alzheimer's Disease1R01AG075827-01 | WINGO, ALIZA PHAMWINGO, THOMAS SPURGEON | EMORY UNIVERSITY, GA | $763,880 | MNG |
| 2022 | Advancing Coordination of Home and Community based Services for the ADRD Population1R01AG075929-01 | ADLER-MILSTEIN, JULIA ROSE | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $757,153 | ODHS |
| 2022 | Immunosenescence, socioeconomic disadvantage and dementia in the US aging population1R01AG075719-01 | AIELLO, ALLISON ENOPPERT, GRACE A | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $756,321 | NAME |
| 2022 | The Role of Ubiquitination in Tau Oligomers Pathogenesis1R01AG077253-01 | KAYED, RAKEZZHAO, YINGXIN | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $748,330 | CMND |
| 2022 | Recruiting and retaining participants from disadvantaged neighborhoods in registries1R01AG077628-01 | GILLEN, DANIEL LGRILL, JOSHUAKIND, AMY J. | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $747,081 | ZRG1 |
| 2022 | The contribution of adult child socio-economic status to parents' risk and outcomes of Alzheimer's disease and related dementias (ADRDs) in cross-national settings1R01AG072448-01A1 | TORRES, JACQUELINE MARIE | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $743,101 | SSPB |
| 2022 | Defective lysosome acidification in dystrophic neurites in Alzheimer's disease contributes to failure of autophagy1R56AG074279-01A1 | SCHRAG, MATTHEW | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $738,781 | ZRG1 |
| 2022 | Dementia prevalence, APOE, and blood-based biomarkers of AD in Native American communities1R01AG080806-01 | MANTYH, WILLIAM G | UNIVERSITY OF MINNESOTA, MN | $737,599 | ZRG1 |
| 2022 | Risk of Alzheimer's Disease and Related Dementias from Perinatal Lead Exposure: Brain Region and Cell Type Effects1R01AG072396-01A1 | BAKULSKI, KELLYCOLACINO, JUSTIN ADAM | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $734,325 | NAL |
| 2022 | LEADing End-of-Life Dementia Care Conversations1R01AG069033-01A1 | DASSEL, KARA BOTTIGGI | UNIVERSITY OF UTAH, UT | $732,521 | SPIP |
| 2022 | A Life Course Approach to Understanding Racial and Ethnic Disparities in Alzheimer's Disease and Related Dementias and Health Care1R01AG077529-01 | CHEN, XI | YALE UNIVERSITY, CT | $729,460 | ZRG1 |
| 2022 | Manipulating Neural Oscillations with Non-Invasive Sensory Stimulation for Alzheimer's Disease Intervention1R01AG069232-01A1 | TSAI, LI-HUEI | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $728,970 | ZRG1 |
| 2022 | Home Health, ADRD, Telehealth, and Patient Outcomes1R01AG078840-01 | MUKAMEL, DANA B | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $727,921 | ZRG1 |
| 2022 | Role of Microglia in Neurodegeneration -Effect of ApoE1R01AG075840-01 | SADOWSKI, MARTIN JOSEPH | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $725,104 | CMBG |
| 2022 | Training the Long-Term Services and Supports Dementia Care Workforce in Provision of Care to Sexual and Gender Minority Residents1R01AG075734-01A1 | ROSSER, B R SIMONSHIPPEE, TETYANA P. | UNIVERSITY OF MINNESOTA, MN | $724,467 | ZRG1 |
| 2022 | Multiethnic machine learning brain signatures of ADRD1R01AG080821-01 | HABES, MOHAMAD | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | $720,673 | ZRG1 |
| 2022 | Clinically Significant Drug Interactions among Nursing Home Residents with ADRD1R01AG077620-01 | ZULLO, ANDREW REIS | BROWN UNIVERSITY, RI | $711,336 | ZRG1 |
| 2022 | The interplay between Tau and ncRNAs – genomic and epigenomic clues to early AD pathogenesis1R01AG077636-01 | KOLDAMOVA, RADOSVETALEFTEROV, ILIYA | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $706,518 | ZRG1 |
| 2022 | Prescribing trends and associated outcomes of antiepileptic drugs and other psychoactive medications in US nursing homes surrounding the COVID-19 pandemic1R01AG074358-01A1 | WINTER, JONATHAN DAVID | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $702,148 | ZRG1 |
| 2022 | Identifying ADRD intervention targets by characterizing neurobiological mechanisms of social isolation, loneliness, and social environment using novel imaging, molecular markers, and machine learning1R01AG079282-01 | APARICIO, HUGO JAVIERBALCER, LAURASALINAS, JOEL ARMANDO | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $696,450 | BGES |
| 2022 | Inactivity, sedentary behavior, and the risk for Alzheimer’s disease in middle aged to older adults1R01AG072445-01A1 | ALEXANDER, GENE EKLIMENTIDIS, YANN CHARLESRAICHLEN, DAVID | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $690,985 | NAME |
| 2022 | Mitigating neuroinflammation and enhancing neuronal integrity in Alzheimer's disease1R01AG072430-01A1 | MA, JIANJIE | UNIVERSITY OF VIRGINIA, VA | $688,260 | ASG |
| 2022 | Regulation of Pathological Tau Transmission by Soluble Tau Post-Translational Modifications1R01NS128964-01 | PENG, CHAO | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $685,674 | CMND |
| 2022 | Seizure-induced enhancement of synaptic signaling regulating tau transmissibility in Alzheimer's Disease1R01AG077692-01 | JENSEN, FRANCES ETALOS, DELIA | UNIVERSITY OF PENNSYLVANIA, PA | $673,961 | ZRG1 |
| 2022 | The impact of Medicare Advantage on Health Care, Management of Comorbid Conditions, and Potentially Inappropriate Medication Use, for Beneficiaries with Alzheimer's Disease and Its Related Dementias1R01AG079216-01 | SHIER, VICTORIA | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $665,619 | ZRG1 |
| 2022 | Circuit mechanisms underlying network disruption and temporal processing deficits in Alzheimer's1R01AG077681-01 | WEHR, MICHAEL | UNIVERSITY OF OREGON, OR | $659,684 | ZRG1 |
| 2022 | Vitamin K and D and Cognitive Impairment in Older Adults2R01AG051641-02 | BOOTH, SARAH LOUISE | TUFTS UNIVERSITY BOSTON, MA | $656,211 | ZRG1 |
| 2022 | The PorchLight Project1R01AG075890-01 | GAUGLER, JOSEPH E. | UNIVERSITY OF MINNESOTA, MN | $655,080 | CMGC |
| 2022 | Predicting long-term cognitive outcomes and Alzheimer’s disease and related dementias after major noncardiac surgery for older adults1R01AG079263-01 | WHITLOCK, ELIZABETH LOUISA | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $654,476 | ZRG1 |
| 2022 | Effects of NAD restoration on neurovascular coupling in community dwelling older adults1R01AG075834-01A1 | THANOU, AIKATERINIYABLUCHANSKIY, ANDRIY | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK | $653,661 | ASG |
| 2022 | Emergency preparedness and support of caregivers of persons with dementia: The Disaster PrepWise study1R01AG077436-01 | ASHIDA, SATO | UNIVERSITY OF IOWA, IA | $647,252 | ZRG1 |
| 2022 | The inflammatory mechanisms underlying olfactory dysfunction in prognosis of TBI progression to dementia1R01AG077541-01 | LIU, SHAOLINWU, JUNFANG | UNIVERSITY OF MARYLAND BALTIMORE, MD | $644,702 | BNRS |
| 2022 | Mental Health Experiences of Hispanic and Latinx ADRD Caregivers1R01AG072569-01A1 | PUGA, FRANK | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $643,902 | ZRG1 |
| 2022 | Deciphering the molecular interplay of sleep and neurodegeneration with Drosophila1R01AG071777-01A1 | BONINI, NANCY MKAYSER, MATTHEW S | UNIVERSITY OF PENNSYLVANIA, PA | $643,393 | BNRS |
| 2022 | Use of Healthcare Across the Full Continuum of Cognitive Health and Decline in Older Adults1R01AG079226-01 | BYNUM, JULIE PWGRODSTEIN, FRANCINE | RUSH UNIVERSITY MEDICAL CENTER, IL | $640,384 | ZRG1 |
| 2022 | Sleep apnea treatment and risk for cognitive decline and Alzheimers disease1R01AG079391-01 | KAUFMANN, CHRISTOPHER NORFLEET | UNIVERSITY OF FLORIDA, FL | $633,966 | ZRG1 |
| 2022 | Effectiveness and adoption of a Smart home-based social assistive robot for care of individuals with Alzheimer's Disease1R01AG075892-01A1 | ARTHANAT, SAJAYBEGUM, MOMOTAZ | UNIVERSITY OF NEW HAMPSHIRE, NH | $611,300 | CMGC |
| 2022 | Neuropathologic-Epidemiological Study of Metallomics and Alzheimer's Disease2R01AG054057-02 | BUSH, ASHLEY ISCHNEIDER, JULIE A. | RUSH UNIVERSITY MEDICAL CENTER, IL | $611,019 | NAME |
| 2022 | Non-Invasive Imaging Markers to Elicit the Role of Vascular Involvement in Alzheimer’s Disease1R01AG075788-01 | JOHNSON, KEVIN MICHAEL | UNIVERSITY OF WISCONSIN-MADISON, WI | $608,186 | EITN |
| 2022 | High-resolution multiplex localization of Alzheimer’s disease risk and resilience factors1R56AG074378-01A1 | NICHOLSON, DANIEL A | RUSH UNIVERSITY MEDICAL CENTER, IL | $606,985 | ZRG1 |
| 2022 | Interactive Effects of Aging and AD on Brain Networks1R01AG072470-01A1 | HOSSEINI, HADI | STANFORD UNIVERSITY, CA | $602,009 | ZRG1 |
| 2022 | Addressing the chronic pain-early cognitive decline comorbidity among older adults; The Active Brains study1R01AG075899-01 | RITCHIE, CHRISTINE SVRANCEANU, ANA-MARIA | MASSACHUSETTS GENERAL HOSPITAL, MA | $594,666 | BMHO |
| 2022 | Simultaneous EEG/fMRI to disentangle neural and vascular mechanisms of Alzheimer's disease pathology1R01AG075753-01A1 | SITNIKOVA, TATIANA | MASSACHUSETTS GENERAL HOSPITAL, MA | $592,581 | ZRG1 |
| 2022 | Effects on the brain microvasculature of age and circadian rhythm as risk factors for Alzheimer's disease1R56AG075988-01A1 | BUSIJA, DAVID W | TULANE UNIVERSITY OF LOUISIANA, LA | $589,530 | ZRG1 |
| 2022 | Contributions of tau-mediated translational dysregulation to pathogenesis and progression of fronto-temporal dementia1R01AG075900-01 | ABISAMBRA, JOSE FRANCISCO | UNIVERSITY OF FLORIDA, FL | $587,504 | ZRG1 |
| 2022 | Thinking about walking: Can digital phenotyping of mobility improve the prediction of Alzheimer's dementia and inform on the pathologies and proteins contributing to this association?1R01AG079133-01 | BUCHMAN, ARON S | RUSH UNIVERSITY MEDICAL CENTER, IL | $582,737 | ZRG1 |
| 2022 | Predictors and consequences of the timing and accuracy of clinical dementia diagnosis1R01AG072559-01A1 | JAMES, BRYAN DAVIDPOWER, MELINDA C | RUSH UNIVERSITY MEDICAL CENTER, IL | $582,706 | NAME |
| 2022 | Microglial heparan sulfate in the modulation of APOE function and neurodegeneration1R01AG072468-01A1 | YAMAGUCHI, YU | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $580,960 | CMBG |
| 2022 | Targeting Microglial Lipoprotein Lipase in Alzheimer's disease1R01AG079217-01 | BRUCE, KIMBERLEY D | UNIVERSITY OF COLORADO DENVER, CO | $569,094 | CMBG |
| 2022 | Tailoring Responses to ADRD Caregivers' InfOrmation wants (TRACO) through human-machine collaboration1R56AG075770-01 | HE, DAQINGXIE, BO | UNIVERSITY OF TEXAS AT AUSTIN, TX | $561,417 | CIDH |
| 2022 | Developing and Evaluating a Surveillance System for Alzheimer's Dementia In the United States1R01AG075730-01 | REIN, DAVID B | NATIONAL OPINION RESEARCH CENTER, IL | $560,906 | SSPB |
| 2022 | Mechanisms by which the ketone body β-hydroxybutyrate counteracts tau pathogenesis1R01AG074273-01A1 | CHEN, XU | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $541,835 | ZRG1 |
| 2022 | Opioid Prescribing Practices and Health Outcomes among Patients with Alzheimer's Disease and Related Dementia1R01AG073442-01A1 | WEI, YU-JUNG “JENNY” | OHIO STATE UNIVERSITY, OH | $540,755 | ZRG1 |
| 2022 | Cholesterol Metabolites as Regulators of Nicastrin1R56AG077637-01 | FERRIS, HEATHER | UNIVERSITY OF VIRGINIA, VA | $539,641 | BPNS |
| 2022 | Elucidating the role of Adaptor Protein complex-4 in regulating axonal autophagic and lysosomal pathways1R01AG074248-01A1 | GOWRISHANKAR, SWETHA | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $533,231 | CMND |
| 2022 | Profiling Psychosocial Dementia Caregiving Networks: The Impact of Dementia Care Networks on Care Outcomes of Medicare Enrollee Persons Living with Dementia1R01AG079097-01 | LEGGETT, AMANDA NOEL | WAYNE STATE UNIVERSITY, MI | $530,370 | ZRG1 |
| 2022 | Effects of the renin angiotensin system on MRI volumetric measures and cognitive function in the Alzheimer's disease process: the LookAHEAD study1R01AG074258-01A1 | YASAR, SEVIL | JOHNS HOPKINS UNIVERSITY, MD | $526,730 | CNN |
| 2022 | Heterotypic amyloid interactions as modulators of selective cellular vulnerability1R01AG079234-01 | ROUSSEAU, FREDERICSCHYMKOWITZ, JOOST | FLANDERS INTERUNIV INST BIOTECHNOLOGY | $523,651 | ZRG1 |
| 2022 | Biobehavioral mechanisms of smartphone-based cognitive emotion regulation training for unpaid primary caregivers of persons with Alzheimer's Disease1R01AG074229-01A1 | DENNY, BRYAN THOMAS | RICE UNIVERSITY, TX | $508,320 | ZRG1 |
| 2022 | The Role of the Hippocampal Vasculature in Vascular Cognitive Impairment and Dementia1R01NS127284-01 | CHAPMAN, ABBIE C | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VT | $497,559 | BINP |
| 2022 | Network and cellular vulnerability to pathological protein progression1R01AG077573-01 | HENDERSON, MICHAEL | VAN ANDEL RESEARCH INSTITUTE, MI | $491,586 | ZRG1 |
| 2022 | The interaction effects of genetic variants, age, diet, sex and mitochondrial copy number on Alzheimer's disease, aging-phenotypes and longevity1R01AG075813-01 | ASHBROOK, DAVID GEORGE | UNIVERSITY OF TENNESSEE HEALTH SCI CTR, TN | $491,351 | MNG |
| 2022 | ROLE OF GLIAL CIRCADIAN CLOCK DYSFUNCTION IN THE PATHOGENESIS OF ALZHEIMER'S DISEASE2R01AG054517-06 | MUSIEK, ERIK STEVEN | WASHINGTON UNIVERSITY, MO | $486,058 | ZRG1 |
| 2022 | APOE4 effects on glia-neuron interaction in the olfactory bulb1R01AG074216-01A1 | LIU, SHAOLIN | HOWARD UNIVERSITY, DC | $469,913 | NIC |
| 2022 | Investigating neutrophilic inflammation as an APOE genotype-specific mediator of cognitive decline and reduced synaptic plasticity in aging1R56AG079224-01 | HENSLEY-MCBAIN, TIFFANY | MC LAUGHLIN RESEARCH INSTITUTE, MT | $450,000 | ZRG1 |
| 2022 | The Longitudinal and Dynamic Effects of Food Insecurity on Cognitive Impairment and Dementia Risk1R01AG079286-01 | LEUNG, CINDY | HARVARD SCHOOL OF PUBLIC HEALTH, MA | $421,154 | SSPA |
| 2022 | Viral IncRNAs Regulate Host Genomic Transcriptional Programs Associated with Sporadic Alzheimer's Disease1R01AG074307-01A1 | ROSENFELD, MICHAEL G | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $416,540 | ZRG1 |
| 2022 | Targeting IDO in SARS-CoV2-induced Alzheimer's Disease progression1R56AG079190-01 | CISNEROS, IRMA | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $400,000 | ZRG1 |
| 2022 | The developmental effects of sex chromosomes and hormones specify microglial inflammation in Alzheimer's diseaes1R01AG075897-01 | REED, ERIN G | NORTHEAST OHIO MEDICAL UNIVERSITY, OH | $390,000 | CMBG |
| 2022 | Deciphering the Molecular Features Underlying LRP1-Mediated Tau Spread1R01AG077672-01 | RAUCH, JENNIFER NICOLE | UNIVERSITY OF MASSACHUSETTS AMHERST, MA | $389,245 | CMND |
| 2022 | Survival genetics methods for detecting sex-dependent genetic effects on Alzheimer’s disease1R56AG075803-01A1 | LI, CHENXI | MICHIGAN STATE UNIVERSITY, MI | $384,456 | BMRD |
| 2022 | Improving Primary Care Clinicians’ Advance Care Planning for Persons Living with Alzheimer’s Disease and Related Dementias1R56AG075896-01A1 | KISTLER, CHRISTINE E | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $380,011 | CMGC |
| 2022 | Skilled Nursing Facility Participation in Health Information Exchange and Quality of Care for Patients with Alzheimer's Disease and Related Dementias1R01AG072605-01A1 | UNRUH, MARK AARON | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $376,778 | ZRG1 |
| 2022 | Epidemiology of blood pressure responses to perturbations: Correlates and prognosis for vascular risk, end-organ damage, cognitive aging and preclinical Alzheimer's disease1R01AG075703-01 | RAMACHANDRAN, VASAN S | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $292,848 | CHSB |
| 2021 | The Emory Healthy Brain Study: Discovering Predictive Biomarkers for Alzheimer's Disease1R01AG070937-01 | LAH, JAMES J | EMORY UNIVERSITY, GA | $7,125,379 | ZRG1 |
| 2021 | Molecular Diversity Among Hippocampal and Entorhinal Cells in Aging and Alzheimer's Disease1RF1AG074341-01 | HUTTNER, ANITA JULIANESESTAN, NENADSTRITTMATTER, STEPHEN M | YALE UNIVERSITY, CT | $4,896,138 | MNG |
| 2021 | The Neighborhoods Study: Contextual Disadvantage and Alzheimer’s Disease and Related Dementias (ADRD)1R01AG070883-01 | BENDLIN, BARBARA BRIGITTAKIND, AMY J. | UNIVERSITY OF WISCONSIN-MADISON, WI | $4,760,115 | ZRG1 |
| 2021 | SARS-CoV-2 and Precursors of Alzheimer's Disease and Related Dementias: An Ultrahigh Field (7T) MRI Study in a Diverse Multinational Cohort1R56AG074467-01 | GIRARD, TIMOTHY DHOSSEINI, AKRAM A.IBRAHIM, TAMER SJACOBS, HEIDI IRMASESHADRI, SUDHAVAHIDY, FARHAAN SHAHEER | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | $3,529,440 | BGES |
| 2021 | Diabetes and brain amyloid in middle aged Hispanics2R01AG050440-06 | LUCHSINGER, JOSE ALEJANDRO | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $3,234,050 | APDA |
| 2021 | Longitudinal Relationships Among Sleep, Cognition and Alzheimer's Disease Biomarkers: Discerning Causal Associations, Mediators and Susceptibility1R01AG070867-01 | PURCELL, SHAUN MREDLINE, SUSAN S. | BRIGHAM AND WOMEN'S HOSPITAL, MA | $3,217,148 | ZRG1 |
| 2021 | The Origins of Alzheimer Disease in Individuals of African Ancestry1R56AG072547-01 | BEECHAM, GARY WAYNEBYRD, GOLDIE S.HAINES, JONATHAN LPERICAK-VANCE, MARGARET A.REITZ, CHRISTIANEWILLIAMS, SCOTT MATTHEW | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $2,962,078 | NAME |
| 2021 | Sleep in Neurocognitive Aging and Alzheimers Research (SANAR)1R01AG067568-01A1 | RAMOS, ALBERTO RAFAEL | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $2,960,566 | CNN |
| 2021 | Epidemiological and Genetic Investigations of Blood-Based Biomarkers for Alzheimer's Disease in the Multiethnic, Washington Heights, Inwood, Columbia Aging Project (WHICAP)1R01AG072474-01 | BRICKMAN, ADAM MMANLY, JENNIFER JAIEMAYEUX, RICHARD P | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $2,730,089 | NAME |
| 2021 | Glucose instability and neurocognitive outcomes in older adults1RF1AG074044-01 | SELVIN, ELIZABETH | JOHNS HOPKINS UNIVERSITY, MD | $2,408,159 | NAME |
| 2021 | Synaptic selectivity for microglial-mediated damage in Alzheimer's Disease1RF1AG070926-01 | STRITTMATTER, STEPHEN M | YALE UNIVERSITY, CT | $2,393,130 | ZRG1 |
| 2021 | "What is N?" Towards operationalizing neurodegeneration in Alzheimer's and related dementias1RF1AG069052-01A1 | GRAFF-RADFORD, JONATHANMIELKE, MICHELLE MVEMURI, PRASHANTHI | MAYO CLINIC ROCHESTER, MN | $2,360,353 | ZRG1 |
| 2021 | Understanding CSF Clearance in Aging and Alzheimerâs Brain Through Dynamic Sodium MRI - Resubmission - 11RF1AG067502-01A1 | QIAN, YONGXIAN | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $2,336,665 | ZRG1 |
Showing the 200 most recent of 430 awards.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.